Neoadjuvant apalutamide (arn-509) and radical prostatectomy in treatment of intermediate to high risk prostate cancer (NEAR) – initial results of a phase II trial

Neoadjuvant apalutamide (arn-509) and radical prostatectomy in treatment of intermediate to high risk prostate cancer (NEAR) – initial results of a phase II trial

Saved in:
Bibliographic Details
Published in:European urology supplements : official journal of the European Association of Urology Vol. 18; no. 1; p. e1394
Main Authors: Aslim, E.J., Yang, X., Ngo, N-T., Khor, L.Y., Chen, K., Chong, T.W., Yuen, J.S.P., Tay, K.J., Ho, H.S.S., Lee, L.S.
Format: Journal Article
Language:English
Published: 01-03-2019
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:1569-9056
DOI:10.1016/S1569-9056(19)31008-5